| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.16 | 0.005 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.089 | 0.008 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |